Gold tier: mechanically validated evidence, with its primary source.
709 evidence items · page 2 / 29
13.2 per_100_person_yearsAfter a median 2.0 year follow-up, the incidence rate of serious HIV-related events was 13.2 per 100 person-years among HIV-HBV co-infected patients.
Côte d'Ivoirehépatite B · VIH/sidapublished 2017The American journal of tropical medicine and hygieneeurope_pmcdocument of 7 observationsDOI 10.4269/ajtmh.16-1016
86.6 %Cumulative proportion of undetectable HBV-DNA was 86.6% in patients with baseline pcG1896A mutation and 66.9% in those without, among antiretroviral-naïve HIV-HBV co-infected patients from Côte d'Ivoire.
Côte d'Ivoirehépatite Bpublished 2018Journal of viral hepatitiseurope_pmcdocument of 7 observationsDOI 10.1111/jvh.12914
32.3 %The main biological effect was hypertransaminasaemia > 2N (32.3%).
Côte d'IvoireVIH/sidapublished 2010Le Mali medicaleurope_pmcdocument of 17 observations
243 cells/mm³Last available CD4(+) T-cell counts were 243 cells/mm³, 245 cells/mm³, and 8 cells/mm³ for the three patients.
Côte d'IvoireVIH/sidapublished 2009Antiviral therapyeurope_pmcdocument of 11 observations
90 %The survival analysis showed a probability of remaining alive and in care of 90% after 24 months.
Côte d'IvoireVIH/sidapublished 2025PloS oneeurope_pmcdocument of 12 observations
86.9 %Prevalence of P. falciparum infection in the LLIN-alone group was 86.9% (2886/3321) post-intervention.
Côte d'IvoirepaludismeHAL · Unilimdocument of 54 observations
360 cells/μlMedian CD4 cell count was 360 cells/μl.
Côte d'IvoireVIH/sidapublished 2014AIDS (London, England)europe_pmcdocument of 9 observations
43.4 %In Survey 2, malaria prevalence was 43.4% among 3234 participants.
Côte d'IvoirepaludismeHAL · Unilimdocument of 122 observations
379 cells/mm³Four hundred seventy-seven patients had a median CD4 count of 379 cells/mm³.
Côte d'IvoireVIH/sidapublished 2021Journal of acquired immune deficiency syndromes (1999)europe_pmcdocument of 6 observations
40.3 %In Côte d'Ivoire, the frequency of multiple infections with msp2 was 40.3%.
Côte d'Ivoirepaludismepublished 2016Journal of parasitology researcheurope_pmcdocument of 8 observationsDOI 10.1155/2016/3074803
7.1 %HIV prevalence among first-time blood donors in Abidjan decreased from 7.1% in 1992–1994 to 1.1% in 2010–2012.
Côte d'IvoireVIH/sidaobserved 1992–1994published 2018Open forum infectious diseaseseurope_pmcdocument of 12 observations
200 USDThe cost of HIV drug resistance testing was assumed to be $200.
Côte d'IvoireVIH/sidapublished 2025The lancet. HIVeurope_pmcdocument of 6 observations
7.3 %HBsAg positivity prevalence among first-time female blood donors in Abidjan was 7.3% in 1992–1994 and 7.1% in 2010–2012.
Côte d'Ivoirehépatite Bobserved 1992–1994published 2018Open forum infectious diseaseseurope_pmcdocument of 12 observations
0.85 per_100_person-yearsThe incidence of severe hyperlactatemia was 0.85 per 100 person-years among women on stavudine-containing antiretroviral regimens in Côte d'Ivoire between April 2005 and May 2009.
Côte d'IvoireVIH/sidaobserved between April 2005 and May 2009published 2010AIDS research and human retroviruseseurope_pmcdocument of 12 observations
2 patientsTwo patients (3.2%) died.
Côte d'IvoireVIH/sidapublished 2010Le Mali medicaleurope_pmcdocument of 17 observations
7.3 %Among HIV-infected pregnant women exposed to nevirapine (NVP) during the first trimester, the proportion of abortion was 7.3%.
Côte d'IvoireVIH/sidaobserved 2003–2009published 2011Journal of acquired immune deficiency syndromes (1999)europe_pmcdocument of 9 observationsDOI 10.1097/qai.0b013e3181ff04e6
10.9 %10.9% of patients were lost to follow-up during antiretroviral chemoprophylaxis.
Côte d'IvoireVIH/sidaobserved 2000-2007published 2010Medecine et maladies infectieuseseurope_pmcdocument of 13 observations
17 participantsSeventeen participants had plasma HIV-2 RNA of 50 copies per mL or greater at least once.
Côte d'IvoireVIH/sidapublished 2024The lancet. HIVeurope_pmcdocument of 7 observations
10.2 %Of 551 HIV-2 patients on ART, 10.2% were lost to follow-up during the median time on ART of 2.4 years.
Côte d'IvoireVIH/sidapublished 2013PloS oneeurope_pmcdocument of 14 observations
29 casesAmong the 128 cases of non-occupational HIV exposure, 29 were due to condom rupture.
Côte d'IvoireVIH/sidaobserved 2000-2007published 2010Medecine et maladies infectieuseseurope_pmcdocument of 13 observations
10 %Among hospitalized HIV-positive adults in West Africa who died, cerebral toxoplasmosis was a fatal disease in 10% of deaths.
Côte d'Ivoirecerebral toxoplasmosis · VIH/sidaobserved 2010published 2014Journal of the International AIDS Societyeurope_pmcdocument of 22 observationsDOI 10.7448/ias.17.1.18797
1.6 %Plasmodium malariae was detected in 1.6% of febrile people in Côte d'Ivoire.
Côte d'Ivoirepaludismepublished 2021Travel medicine and infectious diseasePubMeddocument of 25 observations
0.68 hazard_ratioRisk for tuberculosis was lower in participants given isoniazid preventive therapy and ART than participants given ART alone (hazard ratio 0.68, 95% CI 0.49–0.95, p=0.02).
Côte d'Ivoiretuberculosepublished 2021The lancet. HIVeurope_pmcdocument of 5 observationsDOI 10.1016/s2352-3018(20)30299-x
1.01 aOR_per_50_cells_per_mm3An increase in CD4 cell count between M0 and M24 was associated with being overweight or obese (adjusted odds ratio 1.01 per +50 cells/mm³, 95% confidence interval 1.05–1.13, p = 0.01).
Côte d'IvoireVIH/sidapublished 2016AIDS research and therapyeurope_pmcdocument of 9 observations
75.2 %Among 161 antiretroviral-naïve HIV-HBV coinfected patients in Côte d'Ivoire, 121 (75.2%) had detectable HBV DNA.
Côte d'Ivoirehépatite B · VIH/sidapublished 2016Journal of gastroenterology and hepatologyeurope_pmcdocument of 11 observationsDOI 10.1111/jgh.13156
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.